Avraham Pharmaceuticals' Series D Round

Avraham Pharmaceuticals raised a round of funding on September 17, 2014.

Avraham Pharmaceuticals is a pharmaceutical company developing products for treatment and/or prevention of neurodegenerative disorders. The company's lead product candidate, ladostigil, is in Phase 2 …

Articles about Avraham Pharmaceuticals' Series D Round: